Explore the complexities of tauopathies and how new research could change their diagnosis and treatment approaches.

Researchers showed that in C. elegans, the protein MBD-2 regulates genes through repressive histone marks rather than DNA ...

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by Boston Children's Hospital challenges the current ...

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by Boston Children's Hospital challenges the current ...

Tau protein aggregation is a shared feature in over 20 neurodegenerative diseases (collectively referred to as "tauopathies"). New research led by ...

Kazia Therapeutics , an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, ...

Cancer immunotherapy has transformed modern oncology by harnessing body's own immune system to combat malignant disease.

Support from The Michael J. Fox Foundation for Parkinson’s Research to advance critical research into Parkinson’s disease biology • Nautilus’ development of a single-molecule assay for measuring alpha ...

Figure 1. Dual binding patterns of MBD proteins in mammals and in C. elegans.In mammals (left), previous studies show that most MBD3 binding sites ...

Membrane proteins are vital for cellular signaling, transport, and communication, making them attractive drug targets despite their challenging properties. Advances in mass spectrometry have enabled ...

Detailed price information for Nautilus Biotechnology Inc (NAUT-Q) from The Globe and Mail including charting and trades.